SAN DIEGO -- Results from a small single-center study showed that treatment with a gene therapy involving the use of ...

In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...

Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...

Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...

Haemophilia patients led a deputation to the medical superintendent of the Burdwan Medical College and Hospital today as they were failing to get life saving injections of Factor-VIII & Factor-IX, ...

The weekly or monthly subcutaneous injection has significantly decreased the disease burden for patients with haemophilia A ...

In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...

Indian scientists successfully use gene therapy to treat severe haemophilia A, a rare hereditary condition with promising ...

BHUBANESWAR: In a significant medical breakthrough, India's first human gene therapy with a lentiviral vector for severe haemophilia-A has been found to be succ ...

India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen ...